Comparison of clinicopathologic features and survival between eastern and western population with esophageal squamous cell carcinoma

Journal of Thoracic Disease

Volumn 7, Issue 10, 2015, Pages 1780-1786

  Zhang, Jie ^a,b   Jiang, Yizhou ^a   Wu, Chunxiao ^c   Cai, Shuang ^a   Wang, Rui ^d   Zhen, Ying ^c   Chen, Sufeng ^a,b   Zhao, Kuaile ^b   Huang, Yangle ^a   Luketich, James ^e   Chen, Haiquan ^b,d  

^a FUDAN UNIVERSITY   (China)

^b FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

^c SHANGHAI MUNICIPAL CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^d SHANGHAI JIAO TONG UNIVERSITY   (China)

^e UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

Esophageal squamous cell carcinoma (ESCC); Prognostic factors; Race; Survival

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CAUCASIAN; CHINESE; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROLLED STUDY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; RACE DIFFERENCE; SEX DIFFERENCE; SURVIVAL PREDICTION; SURVIVAL RATE; SURVIVAL TIME; UNITED STATES;

EID: 84947446482     PISSN: 20721439     EISSN: 20776624     Source Type: Journal    
DOI: 10.3978/j.issn.2072-1439.2015.10.39     Document Type: Article

References (24)

1. Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108.
2. Daly JM, Fry WA, Little AG, et al. Esophageal cancer: Results of an American College of Surgeons patient care evaluation study. J Am Coll Surg 2000;190:562-72; discussion 572-3.
3. Hongo M, Nagasaki Y, Shoji T. Epidemiology of esophageal cancer: Orient to Occident. Effects of chronology, geography and ethnicity. J Gastroenterol Hepatol 2009;24:729-35.
4. van Loon AJ, Brug J, Goldbohm RA, et al. Differences in Cancer Incidence and Mortality among Socioeconomic Groups. Scand J Soc Med 1995;23:110-20.
5. Shavers VL, Brown ML. Racial and ethnic disparities in the receipt of cancer treatment. J Natl Cancer Inst 2002;94:334-57.
6. Ayanian JZ, Zaslavsky AM, Fuchs CS, et al. Use of adjuvant chemotherapy and radiation therapy for colorectal cancer in a population-based cohort. J Clin Oncol 2003;21:1293-300.
7. Cronin-Fenton DP, Sharp L, Carsin AE, et al. Patterns of care and effects on mortality for cancers of the oesophagus and gastric cardia: A population-based study. Eur J Cancer 2007;43:565-75.
8. von Bueren AO, Shalaby T, Oehler-Jänne C, et al. RNA interference-mediated c-MYC inhibition prevents cell growth and decreases sensitivity to radio-and chemotherapy in childhood medulloblastoma cells. BMC Cancer 2009;9:10.
9. O'Malley CD, Le GM, Glaser SL, et al. Socioeconomic status and breast carcinoma survival in four racial/ethnic groups-A population-based study. Cancer 2003;97:1303-11.
10. Wang LD, Zhou FY, Li XM, et al. Genome-wide association study of esophageal squamous cell carcinoma in Chinese subjects identifies susceptibility loci at PLCE1 and C20orf54. Nat Genet 2010;42:759-U46.
11. Das A, Singh V, Fleischer DE, et al. A comparison of endoscopic treatment and surgery in early esophageal cancer: An analysis of surveillance epidemiology and end results data. Am J Gastroenterol 2008;103:1340-5.
12. Zhang J, Chen SF, Zhen Y, et al. Multicenter Analysis of Lung Cancer Patients Younger Than 45 Years in Shanghai. Cancer 2010;116:3656-62.
13. Bao PP, Zheng Y, Wang CF, et al. Time Trends and Characteristics of Childhood Cancer Among Children Age 0-14 in Shanghai. Pediatr Blood Cancer 2009;53:13-6.
14. Greenstein AJ, Litle VR, Swanson SJ, et al. Effect of the number of lymph nodes sampled on postoperative survival of lymph node-negative esophageal cancer. Cancer 2008;112:1239-46.
15. Esophageal cancer: epidemiology, pathogenesis and prevention. Nat Clin Pract Gastroenterol Hepatol 2008;5:517-26.
16. Guohong Z, Min S, Duenmei W, et al. Genetic heterogeneity of oesophageal cancer in high-incidence areas of southern and northern China. PLoS One 2010;5:e9668.
17. Zhang W, Bailey-Wilson JE, Li W, et al. Segregation analysis of esophageal cancer in a moderately highincidence area of northern China. Am J Hum Genet 2000;67:110-9.
18. Cui R, Kamatani Y, Takahashi A, et al. Functional Variants in ADH1B and ALDH2 Coupled With Alcohol and Smoking Synergistically Enhance Esophageal Cancer Risk. Gastroenterology 2009;137:1768-75.
19. Tran GD, Sun XD, Abnet CC, et al. Prospective study of risk factors for esophageal and gastric cancers in the Linxian General Population Trial cohort in China. Int J Cancer 2005;113:456-63.
20. Chow WH, Blot WJ, Vaughn TL, et al. Body mass index and risk of adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst 1998;90:150-5.
21. Siassi F, Ghadirian P. Riboflavin deficiency and esophageal cancer: A case control-household study in the Caspian Littoral of Iran. Cancer Detect Prev 2005;29:464-9.
22. Wang J, Wang S, Su J, et al. Food contamination of fumonisin B1 in high-risk area of esophageal and liver cancer. Toxicol Sci 2003;72:188.
23. Steyerberg EW, Neville B, Weeks JC, et al. Referral patterns, treatment choices, and outcomes in locoregional esophageal cancer: A population-based analysis of elderly patients. J Clin Oncol 2007;25:2389-96.
24. Greenstein AJ, Litle VR, Swanson SJ, et al. Prognostic significance of the number of lymph node metastases in esophageal cancer. J Am Coll Surg 2008;206:239-46.